Optimal use of diuretics in patients with heart failure

Jigar Patel1, Michael Smith, J Thomas Heywood

  • 1Scripps Clinic, Department of Cardiology, Mailstop: SW206, 10666 North Torrey Pines Road, La Jolla, CA 92037, USA.

Insights

Diuretics are essential for managing fluid overload in heart failure (HF) but lack large trials. Use the lowest effective dose and discontinue when possible, especially with neurohormonal blockade.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Diuretics are the primary treatment for fluid overload in decompensated heart failure (HF).
  • Despite widespread use, diuretics are not supported by large randomized clinical trials.
  • Their use is considered more art than science due to a lack of definitive evidence.

Purpose of the Study:

  • To review the current understanding of diuretic use in heart failure.
  • To highlight the benefits and drawbacks of diuretic therapy in HF management.
  • To provide guidance on optimal diuretic dosing and discontinuation strategies.

Main Methods:

  • Literature review of current practices and evidence regarding diuretics in HF.
  • Analysis of potential adverse effects and benefits of diuretic therapy.
  • Discussion of alternative management strategies for HF patients.

Main Results:

  • Diuretics effectively relieve congestion in decompensated HF.
  • Potential drawbacks include electrolyte imbalances, neurohormonal activation, hypovolemia, and renal dysfunction.
  • Many HF outpatients can be managed without diuretics once on optimal neurohormonal blockade.

Conclusions:

  • The lowest effective dose of diuretics should be used to achieve euvolemia.
  • Discontinuation of diuretics should be considered when feasible.
  • Optimizing neurohormonal blockade may allow for diuretic-free management in some HF patients.

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...